review🔥emcure pharma ipo apply or not | bansal wire ipo latest gmp
Published 2 weeks ago • 17K plays • Length 8:41Download video MP4
Download video MP3
Similar videos
-
9:14
listing strategy🔥emcure pharma ipo allotment hold or sell | bansal wire ipo latest gmp
-
6:02
final decision🔥emcure pharma ipo apply or not | bansal wire ipo latest gmp
-
2:44
what are brokerages' views on emcure pharma and bansal wire listings?
-
16:03
【2024】首家上市大马创业板的ipo,master tec // #ev #renewableenergy #cable
-
4:37
this infra stock will triple very soon | price - 300 | target - 1000 | multibagger stock
-
8:30
emcure pharma ipo and bansal wire ipo - shocking | bank nifty and nifty analysis | 3/7/2024
-
8:08
final day review🔥emcure pharma ipo allotment chances | bansal wire ipo latest gmp
-
12:03
emcure pharma vs bansal wire ipo review | share market investing
-
11:27
emcure pharma ipo | மூன்று நாளில் 30% profit | 4 fire ratings| #tamilretailtrader #sharemarket
-
1:53
#ipo review | bansal wire industries limited | emcure pharmaceuticals limited
-
5:17
emcure pharma ipo review | bansal wire ipo gmp today | emcure pharma ipo gmp news today
-
4:25
emcure pharma vs bansal wire ipo latest gmp ✅ high allotment chances 💥 retail vs hni listing gain
-
3:16
emcure pharma ipo listed | ipo review & detailed analysis | have you applied?
-
5:14
emcure pharma vs bansal wire ipo latest gmp ✅ high allotment chances 💥 retail vs hni • last date
-
8:00
emcure pharma ipo - opportunity or high valuation? | emcure pharma analysis |
-
4:55
emcure pharma ipo latest gmp ✅ emcure ipo apply or not? 💥 retail vs hni listing gain • apply dates
-
3:36:34
emcure ipo listing | emcure pharma ipo listing | bansal wire ipo | bansal ipo listing | ipo live
-
10:00
after listing 👉🏻 emcure pharma share hold or sell होगा double? | bansal wire ipo hold or sell #smt
-
3:00
emcure pharma ipo launches today; everything you need to know about the pharma company
-
8:01
emcure pharmaceutical ipo| bansal wire ipo| nephro care ipo | all ipo gmp today |
-
0:53
emcure pharma ipo listing: shares debut at nearly 32% premium over ipo price | n18s | cnbc tv18